1. Home
  2. TARA vs ESGL Comparison

TARA vs ESGL Comparison

Compare TARA & ESGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARA
  • ESGL
  • Stock Information
  • Founded
  • TARA N/A
  • ESGL 1999
  • Country
  • TARA United States
  • ESGL Singapore
  • Employees
  • TARA N/A
  • ESGL N/A
  • Industry
  • TARA Biotechnology: Biological Products (No Diagnostic Substances)
  • ESGL
  • Sector
  • TARA Health Care
  • ESGL
  • Exchange
  • TARA Nasdaq
  • ESGL Nasdaq
  • Market Cap
  • TARA 126.5M
  • ESGL 123.1M
  • IPO Year
  • TARA N/A
  • ESGL N/A
  • Fundamental
  • Price
  • TARA $2.80
  • ESGL $3.29
  • Analyst Decision
  • TARA Strong Buy
  • ESGL
  • Analyst Count
  • TARA 7
  • ESGL 0
  • Target Price
  • TARA $20.67
  • ESGL N/A
  • AVG Volume (30 Days)
  • TARA 478.9K
  • ESGL 91.6K
  • Earning Date
  • TARA 08-05-2025
  • ESGL 04-29-2025
  • Dividend Yield
  • TARA N/A
  • ESGL N/A
  • EPS Growth
  • TARA N/A
  • ESGL N/A
  • EPS
  • TARA N/A
  • ESGL N/A
  • Revenue
  • TARA N/A
  • ESGL $6,099,784.00
  • Revenue This Year
  • TARA N/A
  • ESGL N/A
  • Revenue Next Year
  • TARA N/A
  • ESGL N/A
  • P/E Ratio
  • TARA N/A
  • ESGL N/A
  • Revenue Growth
  • TARA N/A
  • ESGL N/A
  • 52 Week Low
  • TARA $1.60
  • ESGL $0.90
  • 52 Week High
  • TARA $10.48
  • ESGL $3.87
  • Technical
  • Relative Strength Index (RSI)
  • TARA 39.61
  • ESGL 61.57
  • Support Level
  • TARA $3.12
  • ESGL $2.94
  • Resistance Level
  • TARA $3.10
  • ESGL $3.87
  • Average True Range (ATR)
  • TARA 0.19
  • ESGL 0.23
  • MACD
  • TARA -0.01
  • ESGL 0.01
  • Stochastic Oscillator
  • TARA 1.39
  • ESGL 40.11

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

About ESGL ESGL Holdings Limited

ESGL Holdings Ltd is a waste management, treatment, and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical, and electroplating companies.

Share on Social Networks: